{
  "trial_id": "NCT03935633",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Thalassemia patients with serum ferritin \u2265 500 \u00b5g/L",
      "label": "met",
      "evidence": "lab study"
    },
    {
      "criterion": "Patients aged 16 and above",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "HB\u226580 g/L before administration",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Voluntarily participate in the experiment, and the process of obtaining informed consent met the requirements of GCP.",
      "label": "met",
      "evidence": "patient text"
    }
  ],
  "exclusion": [
    {
      "criterion": "Hepatitis B surface antigen positive, hepatitis B core antibody positive and HBV-DNA positive",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "HIV positive",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "Patient has a history of sickle cell crises since childhood, but is currently asymptomatic. No liver or renal dysfunction noted.",
  "_meta": {
    "topic_id": "45",
    "trial_id": "NCT03935633",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}